FindMyKOL

Fludiona Naka, MD, MPH

Basic profile

Dermatology

ORCIDOn fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionFarmington, CT · NortheastSpecialtyDermatologyFocusDermatology
Active KOLFindMyKOL type: RegionalLatest publication2020Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Fludiona Naka is a Dermatology physician. OpenAlex indexes 11 publications with 293 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
11publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

293citations

Citations across these publications.

8h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
25companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Industry payments

25 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Janssen Biotech, Inc.
    Program year202520 payments
    $440
  • UCB, Inc.
    Program year202516 payments
    $387
  • ABBVIE INC.
    Program year202517 payments
    $347
All 66 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    27.8%
    Azole Antifungal13.4%
    Ketoconazole100%
    Part D≥64 patients
    Tetracycline-class Drug9.9%
    Doxycycline Monohydrate100%
    Part D≥37 patients

    + 2 more classes in this area

  • Dermatology

    24.3%
    Corticosteroid10.8%
    Triamcinolone Acetonide100%
    Part D≥57 patients
    Interleukin-4 Receptor alpha Antagonist9.4%
    Dupixent Pen87%Dupixent Syringe13%
    Part D<11 patients

    + 2 more classes in this area

  • Sensory organs

    19.2%
    Corticosteroid19.2%
    Clobetasol Propionate50%Betamethasone Diprop Augmented27%Hydrocortisone23%
    Part D≥48 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

All 11 publications: search, sort and filter.Explore →

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”